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amino acids, organic acids and glucose using HPLC-UV-Vis and HPLC-MS
with screening via NMR
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Vicente Montiel,a Craig E. Banksc and Jesus Iniesta*a
Received 23rd September 2011, Accepted 7th October 2011
DOI: 10.1039/c1ay05610gA simple, rapid, sensitive and selective procedure based on the combination of HPLC-UV-Vis and
HPLC-MS has been developed and single laboratory partially validated for the determination of a set
of 13 analytes present in a commercially available IVF medium utilising small sample volumes (20–30
mL). The composition fingerprint of the complex sample obtained by NMR spectroscopy in 11 minutes
provided identification based on a screening of the metabolomic profile. HPLC-MS allowed the
glucose–sodium adduct to be measured accurately and the working and linear ranges achieved were
0.028–0.389 mmol L1 with a detection limit of 13 mM. HPLC-UV-Vis allowed accurate concentrations
of pyruvic and lactic acids with linear ranges over 0.005–0.1 mmol L1 with a limit of detection of 28
mM for pyruvic acid to be determined in 8 minutes, while lactic acid presented a linear range over 0.1–2
mmol L1 with a limit of detection of 1.2 mM possible. The use of HPLC-UV-Vis allowed the
chromatographic separation of 8 amino acids (aspartate, glutamate, serine, glycine, asparagine,
glutamine, alanine, and proline), the dipeptide alanyl-glutamine and taurine previous to a chemical
derivatization, providing a total run time of 40 minutes. The method was partially validated to show
a linear range of 0.028–0.280 mmol L1 with detection limits ranging between 1 and 30 mM.
Development of the analytical approach provided determination and quantification of a set of 13
analytes from a very complex sample. Although well established analytical techniques were used here,
combinatory methodologies were partially validated for the first time to this purpose. The novelty of
the combination of techniques relies on a screening tool and a strategy to the future evaluation and an
improved assessment of human embryo viability.1. Introduction
Requirements in reproductive biomedicine for the improvement
of in vitro fertilization (IVF) rates involve the evaluation of
embryo morphology, the embryo viability to implant, and the
optimum complex medium composition.1 Parameters evaluated
to select the best embryo to transfer are embryo morphology and
embryo development during cleavage from blastocysts to morula
stage.2 However, contrary to the expected results, sometimes
embryos considered as inappropriate may end up with a positiveaPhysical Chemistry Department and Institute of Electrochemistry,
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This journal is ª The Royal Society of Chemistry 2011development while conversely embryos considered as appro-
priate may not.
Immense effort has been put into the study and optimisation of
the perfect culture medium composition because although the
embryo nutritional needs in early stages of development are
reflected in the female tract, in vitro conditions are not definitely
known and consequently the necessary elements for the cell
growth are unknown.3 For example, during the first day of
cleavage in vitro, the embryo has a low metabolic rate, with
a limited capacity to use glucose and so generates energy from
low level oxidation of pyruvate, lactate4 and nonessential amino
acids.5,6 After the compaction, the embryo begins consuming
glucose4 through oxidative glycolysis and utilises nonessential
and essential amino acids for cellular proliferation and differ-
entiation.2,3,7,8 Generally amino acids are critically involved in
functional pathways including the biosynthesis of intermediates,
metal chelators or antioxidants, the sources of energy and also
are related with the regulation of the energy metabolism.9 Several
strategies have been proposed to improve the embryo culture
medium,3,11 and recent research in the field has focused uponAnal. Methods
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View Onlineexamining correlations between the consumption and excretion
of metabolites with success of implantation.10 Since the 1990s
some researchers have attempted to monitor metabolites such as
lactate and pyruvate as reported by Conaghan and co-workers,11
and others have focussed on glucose9,12 and their effects on the
determination of pregnancy rates in embryos.
Most of these reported analytical determinations entail
complex and lengthy analysis requiring expensive equipment
such as ultramicrofluorescence spectroscopy.13 This analytical
approach has been reported to be useful for the determination of
the above metabolites using small sample volumes, typically
microlitre volumes of a simple culture medium which lacks
essential components such as amino acids. However, the scenario
is completely different when analysts wish to tackle the analytical
monitoring of a wide number of metabolites, including amino
acids, vitamins, and proteins.
More recently, despite the complexity of commercial culture
media, non-invasive and elaborate methodologies used in
metabolomics and based on chemical monitoring,14 proteomic
assessment,15 and spectroscopic techniques10,16–19 have emerged
and they have been used, in addition to the morphologic methods
or genetic methods,20 to assess embryo viability. These studies
have facilitated and improved the effectiveness of assisted
reproduction techniques (ARTs), enabling better embryo selec-
tion and reducing the number of transferred embryos.
In that respect, metabolomics is the science of small molecules
which are involved in biochemical processes and it has been
shown that this approach can provide a great deal of information
regarding the ‘‘real-time’’ situation of a biological system within
a biochemical approach.21 Metabolomics is the process of
simultaneous monitoring and evaluating changes and dynamics
of biological systems.22 The need of analysing simultaneously the
plethora of metabolites in biological fluids such as cell or tissue
extracts, urine, plasma, and seminal, amniotic23 or cerebrospinal
fluids has consequently made metabolomics an encouraging
science which can provide an integrated view of the whole
system.24 Note that not only is metabolomics focused on
biomedical studies but also has uses in other areas such as
studying wine fermentation and evaluating malolactic fermen-
tative characteristics of yeast strains.25,26 The majority of these
metabolomic studies include HPLC chromatography coupled
with UV-Vis, fluorescence, refraction index or electrochemical
detectors, as well as more sophisticated techniques such as mass
spectrometry and high field nuclear magnetic resonance. Partic-
ularly, some of these have been used for the monitoring of
embryonic culture media, including the study of amino acids
(alanine, glutamate and leucine) and glucose, lactate and pyru-
vate17 via NMR and the analysis of embryo protein expression
(secretome) by surface enhanced laser desorption and ionization
time-of-flight mass spectrometry (SELDI-TOF-MS) by using
ubiquitin as the protein biomarker.27 We note that the current
state of the literature reflects individual techniques towards
determining these identified metabolites and it appears that
a complete combinatory approach has not been reported
towards metabolomic studies, particularly in IVF culture media.
Consequently, in this paper, we report a combinatory pool of
the main analytical techniques employed for metabolomic
studies which are based on conventional liquid chromatography
(LC), mass spectroscopy (MS) and nuclear magnetic resonanceAnal. Methodsspectroscopy (NMR).28 Mass spectrometry requires a pre-sepa-
ration of the metabolic components using either LC or gas
chromatography (GC). To the best of our knowledge, there are
no reported studies on the characterization of a commercial
embryo culture medium using this combination of techniques.
Additionally, in this work, we exploit LC as a routine and
accessible technique at many chemical and biological laborato-
ries for the determination of ten amino acids previously via
derivatisation as well as glucose and two organic acids, lactic and
pyruvic. Simultaneously, we take advantage of mass spectrom-
etry and NMR as complementary techniques to LC. In that
respect, due to the complexity of isolation of interferences such as
hyaluronic acid (HA, an anionic, non-sulfated glycosamino-
glycan) present in the culture media, glucose required the use of
LC coupled with mass spectrometry. Furthermore, NMR spec-
troscopy is a powerful, interdisciplinary method and a non-
destructive technique which can provide information on the
molecular structure of both pure compounds and complex
mixtures as well as information regarding absolute or relative
concentrations. In particular, the NMR results obtained here,
using 800 MHz for the first time, contribute simultaneously to
both the determination of new molecules and act as a general
fingerprint of the whole metabolomic profile of the culture
medium.
The aim of this study is to combine well-known analytical
techniques such as HPLC-UV-Vis, HPLC-MS and a more
powerful technique such as high field 1H (800 MHz) NMR
spectroscopy to separate and determine a complex commercially
available IVF culture medium. Moreover, partial validation of
our method enhancement has been carried out taking into
consideration the following issues: sensitivity, selectivity, limit of
detection, limit of quantification, linearity and range. The IVF
medium constitutes among others glucose, organic acids: lactic
and pyruvic, amino acids: aspartate (Asp), glutamate (Glu),
serine (Ser), glycine (Gly), asparagine (Asn), glutamine (Gln),
alanine (Ala), and proline (Pro), the dipeptide alanyl-glutamine
(Ala-Gln) and taurine (Tau), and other compounds such as
hyaluronic acid (HA) and proteins like human serum albumin
(HSA). Herein we present a combinatorial approach for the
overall determination of analytes in this complex medium by
sensitive, rapid, simple and selective techniques which allow the
exclusion of interferences. The major achievement of this work
for the embryological community will be supported on the basis
of the determination of a wide number of analytes. Such results
could be used for the evaluation and further comparison of the
real culture medium after the embryo incubation process and
therefore to the optimised embryo selection yielding in an
improved implantation.2. Materials and methods
Chemicals used were of analytical grade which include D2O
(Sigma, 99.9%), sodium 3-(trimethylsilyl)propionic acid (TSP)
(Sigma, 99.9%), formic acid, acetic acid and ortho-phosphoric
acid (Sigma, 99.9%), phenylisothiocyanate (PITC, Acros
Organics, 99%), ethanol (Merck, absolute analysis) and aceto-
nitrile (Scharlau, HPLC grade). Sodium pyruvate, sodium
lactate, glucose, Asp, Glu, Gly, Asn and Pro were purchased
from Fluka with a purity >99.9%. Ala, Ser, Gln and the Ala-GlnThis journal is ª The Royal Society of Chemistry 2011
Table 1 HPLC gradient for amino acids determination
Linear gradient compositiona
Time/min A (%) B (%)
0.0 100.0 0.0
21.0 96.5 3.5
29.0 96.5 3.5
40.5 92.5 7.5
42.5 92.5 7.5
45.5 0.0 100.0
65.5 0.0 100.0
76.0 100.0 0.0
a Solvent composition A: 50 mmol L1 sodium acetate adjusted to pH 5.5
with acetic acid, B: acetonitrile.
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View Onlinewere purchased from Merck, with a purity >99%. Buffer salt
solutions consisted of pH 5.5 sodium acetate adjusted with acetic
acid from Scharlau and pH 7.0 potassium phosphates from
Fluka. All solutions were prepared with doubly deionised water
of resistivity not less than 18.2 MU cm1.
The IVF culture medium (G-1 v5 PLUS) was purchased
from Vitrolife (G€oteborg, Sweden), and was used as received
and also contained other analytes: Ala, Ala-Gln, Asn, Asp, Glu,
Gly, Pro, Ser and Tau; glucose, sodium lactate, sodium pyru-
vate, sodium citrate, lipoic acid, gentamicin, HA and HSA. The
pH for this buffered medium measured at 37 C and an atmo-
sphere of 6% CO2 was 7.29 and the osmolality was 264 mOsm
kg1. The supplying company wishes to keep the quantitative
composition of this medium confidential and no concentrations
have been reported in the literature. Therefore, the composition
of this medium is only qualitatively known. The medium was
stored at 20 C and therefore it was thawed at room
temperature for 15 minutes prior to vortexing for 6 seconds.
Samples were filtered through a 0.45 mm PTFE filter prior to
analysis. The experimental procedure of frosting and defrosting
the samples from 20 C up to room temperature was found to
have no effect on the different cycles as low variability in the
results was shown.
NMR experiments were performed with a Bruker Digital
Advanced 800 MHz (Bruker, Germany) coupled with a cryo-
probe and settled at 300 K. A portion of 20 mL of samples was
used because this is the expected volume in real samples. In order
to minimize the dilution of the samples, 3 mm NMR tubes
(Norell, Landisville, USA) were used. So, 20 mL of samples were
diluted to 150 mL in 0.9% NaCl, 1 mM TSP as internal reference
and 10% D2O. To analyze low molecular weight metabolites,
a Carr–Purcell–Meiboom–Gill (CPMG) pulse sequence29 was
acquired with 128 scans, a spectral width of 20 ppm and 65k data
points, and the experimental time was ca. 9 minutes. A 5 s
relaxation delay was applied between scans. For further analysis
of metabolites 1D-nuclear Overhauser effect spectroscopy
(NOESY) spectra were used with 10 ms of mixing time, 128 scans
and a relaxation delay of 5 s. For the assignment of the metab-
olites, J-resolved 1H and 2D- 1H–13C heteronuclear single
quantum coherence (HSQC) experiments were used. Spectra
were Fourier transformed and adjusted with TopSpin 2.1
(Bruker BioSpin, Rheinstetten, Germany). Spectra were cali-
brated using TSP as a reference, and metabolites were assigned
using Amix software in combination with the Bruker NMR
Metabolic Profiling and BioMagResBank.
Glucose analysis was carried out with HPLC coupled with
a mass spectrometer (Agilent 1100 LC/MSD Trap SL model)
with a positive ion polarity in the electro spray ionisation (ESI).30
The column used was a LichroCART, with LichroSpher as the
stationary phase, 4.0  250 mm, 5 mm, (Agilent Technologies).
The mobile phase consisted of a mixture of acetonitrile/water
75 : 25 v/v + 0.1% formic acid, and an isocratic flow rate of 0.5
mLmin1. The injection volume after dilution up to ten-fold with
water was 10 mL. Positive ionization was chosen for glucose
determination and in all cases before glucose determination,
calibration curves were obtained following the ion abundance of
203-mass corresponding to the mass of the adduct [Glucose +
Na]+. Calibration curves for determination of glucose were per-
formed over days in order to follow the possible variations of theThis journal is ª The Royal Society of Chemistry 2011equipment associated with electrospray conditions, type of
source or sample contamination.
Lactic and pyruvic acids concentrations were determined by
HPLC (Agilent 1100 series, Santa Clara, USA) coupled with an
UV-Vis detector. The mobile phase consisted of 20 mol L1
NaH2PO4 aqueous solution adjusted to pH 2.5 with H3PO4. The
column used was a C18 Hypersil octadecylsilane (ODS), 4.0 250
mm, 5 mm, with the temperature setup at 25 C. The flow rate was
0.5 mL min1 with a wavelength of 210 and 220 nm, although in
both cases more sensitive signals were obtained for 210 nm. After
a proper ten-fold dilution with water, injection volumewas 20 mL.
The amino acids analysis, Asp, Glu, Ser, Gly, Asn, Gln, Ala,
Pro, Ala-Gln and Tau, was preceded by the albumin protein
removal. HSA contained in the culture medium was precipitated
with ethanol as a co-solvent and then centrifuged in a micro-
centrifuge at 14 000 rpm for 15 min (or a relative centrifugal force
(RCF) of 573 (g)). Finally, the supernatant was removed and
samples were filtered through a 0.45 mm PTFE filter prior to
analysis. The amino acids were chemically derivatized off column
by the use of 2 mLof phenylisothiocyanate (PITC), as described by
Heinrikson and Meredith;31 the derivatisation implied incubating
the samples for 30 minutes at 37 C. In order to ensure a high
recoveryof aminoacids and full derivatisation this stepwas carried
out in an excess of derivatisingagent.Then sampleswereapplied to
a HPLC-UV-Vis (Agilent 1100 Series) system measuring at
a wavelength of 254 nmwith a C18 Hypersil ODS column of 4.0
250 mm and 5 mm particle size. A gradient mode consisting of two
mobile phases was used: mobile phaseAwas 50mmol L1 sodium
acetate adjusted to pH 5.5 with acetic acid and B was acetonitrile.
The column was eluted under linear gradient conditions at
a constant flow rate of 1.0mLmin1 as presented inTable 1.Aflow
of 100% acetonitrile was used during 26 minutes to wash the
columnand remove theunreactedPITC.After a proper dilutionof
1 to 7.2, the injection volume of the derivatized sample was 5 mL.
3. Results and discussion
3.1. Assignment by 1H 800 MHz NMR
Fig. 1 presents the CPMG spectra showing the metabolic profile
of the IVF culture medium with several peaks derived from its
complex composition. Table 2 summarises the metabolites, their
chemical shifts and the assignation of the peaks for the 1H NMR
spectrum. Peaks for the eight amino acids: Ala, Glu + Gln, Gln,Anal. Methods
Fig. 1 Full CPMG spectra. A total of 14 metabolites can be identified:
(1) lactic acid; (2) Ala; (3) Ala-Gln; (4) Glu + Gln; (5) pyruvic acid; (6)
Gln; (7) citric acid; (8) Asp; (9) Asn; (10) Tau; (11) Gly; (12) glucose; (13)
Ser; (14) Pro.
Fig. 2 Zoom of the chromatogram (A) and mass spectrum (B) for
glucose determination in the IVF culture media.
Table 2 Metabolites and their chemical shifts of assigned peaks for the
1H NMR assignment
Analyte Chemical shift/ppm
TSP 0.00
1 Lactate 4.11 (CH); 1.33 (CH3)
2 Ala 1.45 (CH3)
3 Ala-Gln 1.55 (CH3); 2.00 (CH2); 2.33 (CH2)
4 Glu + Gln 2.15 (bCH2)
5 Pyruvic acid 2.37 (CH3)
6 Gln 2.40; 3.72 (aCH)
7 Citric acid 2.55 (CH2); 2.70 (CH2)
8 Asp 2.62 (bCH2), 2.64 (bCH2); 3.86 (aCH)
9 Asn 2.79 (bCH2), 2.81 (bCH2)
10 Tau 3.25 (CH2); 3.41 (CH2)
11 Gly 3.48 (aCH2)
12 Glucose 3.46; 3.50; 3.52 (CH2)
13 Ser 3.85; 3.91 (bCH2)
14 Pro 4.20 (aCH)
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View OnlineAsp, Asn, Gly, Ser and Pro, and the dipeptide Ala-Gln and
Tau were observed as well as peaks for lactic and pyruvic acids
and glucose. Additionally, peaks at 2.55 and 2.70 ppm were
assigned to citric acid; however no assignment for lipoic acid was
possible.
NMR metabolomics is a new, fast and incredibly useful tool
for obtaining the medium metabolomic fingerprint, which gives
a quick idea of its profile. The NMR analyses are non-invasive as
the sample is diluted with saline solution and the duration of the
analysis is very short (ca. 9 minutes). Therefore, if a small
amount of sample is acquired it can be difficult to perform
enough measurements to obtain the required information
without significant dilution and here, as the sample is not
destroyed, it may be recovered and used in further analyses.
Advantageously, in these experiments there is no need for
deproteinization procedures as pulse sequences are designed for
lifting the proteins. The use of an 800 MHz NMR equipment is
not a common facility and it also requires high costs. Although
lower field equipment (400, 500 and 600 MHz) can be used,
plenty of disadvantages appear as acquisition times grow, higher
sample volumes are needed and resolution power decreases.Anal. Methods3.2. Determination of glucose by HPLC-MS
We first consider the determination of glucose in IVF culture
media. Simultaneous detection of glucose together with the
organic acids (lactic and pyruvic) determination was not viable as
glucose concentrations were below the detection limit; glucose
adsorption wavelength is below 210 nm and additionally has
a very small extinction coefficient. However, HPLC coupled to
a refractory index detector (HPLC-RID) is an established tech-
nique for the determination of sugars in different samples.32,33
However, our preliminary determination of glucose using
HPLC-RID presented one main drawback related to interfer-
ences of HA, lactic and pyruvic acids present in the culture
medium with retention times close to that for glucose. Conse-
quently, our glucose analyses turned out to be relatively higher
than previously reported.2 Therefore, mass spectrometry was
used to determine glucose concentrations as a precise and
selective technique for metabolomics studies.
Fig. 2 depicts the mass spectrum for the culture medium
analysed. A positive ionization polarity was chosen and three
adducts were detected, +H+ (m/z ¼ 181), +Na+ (m/z ¼ 203), and
+K+ (m/z ¼ 219) but overall the most abundant target mass and
therefore the selected one was that corresponding to the 203-
mass respective to the [Glucose + Na]+ adduct. The glucose
retention time for these conditions was 11.4 minutes and a linear
calibration curve in ultra pure H2O over a range of 0.028–0.389
mmol L1 was obtained with a slope of 168.067 mmol1 L (R2 ¼
0.9996). The final concentration of glucose of this IVF medium
was calculated to be 0.461  0.004 mmol L1 (in all cases using
Student’s-t for 95% probability and a sample of n ¼ 8) from the
calibration plots and achieved a detection limit of 13 mM and
a limit of quantification of 44 mM.
Attempts on the direct infusion to the mass spectrometer of the
IVFmedium were contemplated as a feasible analytical approach
in order to decrease the analysis time. Although we diluted the
sample with water, the high osmolality (between 270 and 290
mOsm in physiological media) provoked capillary blocking.
Hence, the use of a carbohydrate HPLC column benefited the
separation of salts and complex analyte mixtures and we could
target glucose with no need for deproteinization. Once glucoseThis journal is ª The Royal Society of Chemistry 2011
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View Onlinewas separated, this was identified and quantified with the mass
spectrometer following either scan mode or secondary ion mass
spectrometry (SIM) mode. Within a scan range between 35 and
500 m/z no additional carbohydrates were found. Furthermore,
SIM mode was used successfully for the quantification of the
sodium–glucose most abundant adduct with a higher sensitivity.
Glucose determination can be also followed by enzymatic
assay using ultramicrofluorescence where glucose is first con-
verted via enzymatic catalysis to glucose-6-phosphate in the
presence of adenosine-50-triphosphate (ATP).13 Further, the
latter compound is converted enzymatically to 6-phosphoglu-
conolactone with the additional production of the nicotinamide
adenine dinucleotide phosphate (NADPH). Although this fluo-
rimetric method requires a small portion of the sample, 1–2 mL,
the protocol involves generally extensive analyses time. Different
strategies for the determination of glucose in cell culture or
biological fluids are now emerging. Electrochemical devices and
microdevices focused on the monitoring of different analytes
involved in cell growth and this development has been com-
mercialised. For example, Pereira and collaborators measured
the real-time monitoring of glucose in cell culture by using
microfluidic electrochemical biochips.34 Nevertheless, the rapid
determination of glucose with an electrochemical commercial
device commonly used by diabetic people was unfeasible and the
authors speculate that the surface was quickly blocked.3.3. Determination of lactic acid and pyruvic acid by HPLC-
UV-Vis
We now turn towards the analysis of lactic and pyruvic acids in
the IVF culture medium utilising a HPLC-UV-Vis detector.
Fig. 3 depicts a typical chromatogram arising from the IVF
culture medium at a dilution of 1 to 10 in phosphate buffer
solution pH 7.0 for an injection volume of 20 mL. As depicted in
Fig. 3, peak A corresponds to pyruvic acid and peak B to lactic
acid, based on comparison with analytical standards. Calibration
curves for pyruvic acid were obtained in an aqueous solution
consisting of 20 mM phosphate buffer pH 2.5 and measured at
210 nm wavelength which exhibits a retention time of 5.69Fig. 3 Typical chromatogram of the IVF culture medium clearly
demonstrating the eluted peaks of pyruvic acid (tr¼ 5.742 min) and lactic
acids (tr ¼ 7.284 min).
This journal is ª The Royal Society of Chemistry 2011minutes. A linear response to increasing concentrations of pyr-
uvic acid over a range of 0.005–0.1 mmol L1 was obtained with
a slope of 1276.2 mmol1 L (R2 ¼ 0.9998). Lactic acid was found
to exhibit a retention time of 7.28 minutes giving a linear
response over the concentration range studied, 0.1–2 mmol L1,
with a slope of 77 mmol1 L (R2¼ 0.9999). The chromatographic
characterisation for pyruvic and lactic acids determination was:
the resolution factor (Rs) was 6.564, the capacity factor (k
0) of
pyruvic acid was 0.317 and for lactic acid 0.671, and the selec-
tivity factor (a) for the two peaks was found to be 2.116. The
analytical utility of the HPLC for the quantification of these two
organic acids has been proven and at concentrations of 0.395 
0.008 mmol L1 (Student’s-t 95%, n ¼ 8) of pyruvic acid and 19.9
 0. 3 mmol L1 (Student’s-t 95%, n ¼ 8) of lactic acid has been
calculated for the culture medium from the calibration plots,
showing detection limits / quantification limits of 28 / 92 mM and
1.2 / 3.9 mM, respectively.
Despite HSA being present at a high concentration in the
culture medium ca. 5 mg mL1 deproteinisation was not required
for the inter-day determination of both organic acids. Further-
more and as previously mentioned in the Experimental section,
the only sample preparation which needed deproteinisation with
ethanol was the determination of the amino acids. The effect of
pH in the range between 2.0 and 3.0 was evaluated to observe the
potential effect on the resolution of the pyruvic acid peak but
a pH of 2.5 was found to be the optimum pH. Rapid determi-
nation of lactic and pyruvic acids was achieved in 8 minutes
without further purification or elimination of macromolecules
such as HA and HSA.
Pyruvate has been commonly investigated via fluorescence
methods, electrochemical detectors coupled with HPLC, spec-
troscopic methods or enzymatic reactions. Wulkan and co-
workers used HPLC coupled to a fluorescence detector to
analyse pyruvate in a complex matrix of blood.35 Recently,
Wolff36 and collaborators compared HPLC with two detection
methods: fluorescence versus enzymatic assay to measure pyru-
vate in blood in clinical practices, taking into account that the
fluorescence method required a derivatisation step. Alterna-
tively, the enzymatic assay is based on the reduction of pyruvate
to lactate by lactate dehydrogenase at pH 7.5 with the nicotin-
amide adenine dinucleotide (NADH) in excess. The concomitant
oxidation of NADH is then measured by fluorimetric detection13
or spectrophotometrically at 340 nm. The latter procedure
presents several drawbacks since the recovery can be insufficient
and therefore is considered as estimation for pyruvate in blood.37
HPLC-RID has also been postulated as an analytical option
for lactate determination in a wide variety of media such as blood
plasma, serum, and wine.38 Likewise, electrochemical and fluo-
rimetric detectors are also commonly used for the determination
of lactate of different media natures.39,40 On one hand, electro-
chemical detectors require working at isocratic flow as well as
relative conductive mobile phases, presenting a main drawback
and passivating carbonaceous electrodes.41 On the other hand,
the use of microfluorimetric detectors requires derivatisation of
most samples.42
Here, the rapid determination of lactic and pyruvic acids
concentration is crucial as this allows us to determine the lactate
to pyruvate ratio in this culture medium, which is biologically
significant as this reflects the cellular NADH to NAD+ ratio.Anal. Methods
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View OnlineThis factor named the relative redox potential can be used as an
indicator of the redox status and the kinetics of the embryo
development.433.4. Determination of amino acids, taurine and alanine-
glutamine by HPLC-UV-Vis
Fig. 4 depicts the response for eight amino acids identified in the
IVF culture media, Asp, Glu, Ser, Gly, Asn, Gln, Ala, and Pro,
the dipeptide Ala-Gln and Tau, when analysed by HPLC-UV-
Vis at 254 nm. Table 3 presents the correlation of the peak
number (N), the analyte assignment, and the retention time (tr) as
well as the calibration curve slopes (a), the y-intercept value (b)
and its regression coefficients (R2) over a studied range of 0.028–
0.280 mmol L1 for the cited amino acids.
Accordingly, the concentration of each analyte in the IVF
culture medium with this method was calculated from the
calibration plots to be Asp 0.670  0.002 mmol L1, Glu
0.540  0.001 mmol L1, Ser 0.565  0.003 mmol L1, Gly
0.2616  0.0004 mmol L1, Asn 0.3879  0.0005 mmol L1, Gln
0.1070  0.009 mmol L1, Tau 0.364  0.001 mmol L1, Ala
0.880 0.003 mmol L1, Pro 0.2734 0.0006 mmol L1 and Ala-
Gln 0.570  0.001 mmol L1 (in all cases using Student’s-t for
95% probability and a sample of n ¼ 7). The detection / quan-
tification limits achieved with this separation totally assure theFig. 4 Zoom of the chromatogram of the IVF culture medium showing
the eluted peaks of the amino acids: (1) Asp; (2) Glu; (3) Ser; (4) Gly; (5)
Asn; (6) Gln; (7) Tau; (8) Ala; (9) Pro; and (10) Ala-Gln.
Table 3 Amino acids analysis parameters
N Analyte tr/min a/mmol
1 L
1 Asp 10.95 939.219
2 Glu 13.58 994.09
3 Ser 16.22 1075.040
4 Gly 17.96 3437.387
5 Asn 18.74 1371.424
6 Gln 21.26 1156.226
7 Tau 23.30 2597.375
8 Ala 27.29 694.865
9 Pro 29.52 4980.587
10 Ala-Gln 35.18 3783.921
Anal. Methodssuitability of this technique for the analysis of this complex
medium, as referred before, and following the same order of
appearance as they were: 8 / 27 mM for Asp, 4 / 14 mM for Glu,
9 / 30 mM for Ser, 1 / 4 mM for Gly, 2 / 5 mM for Asn, 30 / 102 mM
for Gln, 3 / 12 mM for Tau, 10 / 32 mM for Ala, 2 / 7 mM for Pro
and finally, 4 / 12 mM for Ala-Gln.
As mentioned in the Experimental section, the deproteiniza-
tion step was essential in the amino acids determination, so it was
carried out using ethanol as co-solvent. It is well known that
PITC can react with N-terminus of proteins as well as amino
groups of lateral chains in amidic amino acids.31 There are two
types of amino acids, essential and non-essential, and depending
on the embryo developmental stage they could be taken in by
cells, where they undergo further degradation, i.e. catabolic
processes, or used as a nitrogen source. The uptake and depletion
of amino acids are related to the growth and development of
human embryos.14
3.5. Analysis of dataset
In this step now we turn to summarise the results obtained from
the four determinations in order to get insight into the nature of
the culture medium, the time of analysis and the feasibility of the
measurements. Fig. 5 shows the global scheme for a complex
medium analysis. This figure emphasizes on the analytical plat-
form developed, where generally in IVF the sample volumes are
between 20 and 30 mL after human embryo retrieval. The first step
tackles the qualitative and fingerprint analysis of the sample,
which does not require any chemical modification. Thereafter, the
whole sample could be redirected to the chromatographic
measurement for the quantitative determination of analytes, inb R2 k0 a
12.649 0.9901 3.380 1.311
19.655 0.9803 4.432 1.238
16.610 0.9852 5.488 1.127
52.219 0.9849 6.184 1.050
20.155 0.989 6.496 1.155
17.352 0.9877 7.504 1.109
26.857 0.9914 8.320 1.192
12.743 0.9821 9.916 1.090
37.885 0.9912 10.808 1.209
36.560 0.9902 13.072 0.076
Fig. 5 Scheme of the steps required for a completion of the combina-
torial analytical platform.
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View Onlinethis case organic acids and glucose. The amino acids determina-
tion step is placed at the end of this platform since it involves the
chemical modification of the sample. In conclusion, the analytical
platform manages the identification and quantification of the
sample and provides the analyst with the metabolomic profile of
the micro IVF fluid after retrieval of embryos. Furthermore, this
analytical platform could be applied to many kinds of culture
media commonly used. The analytical platform requires minimal
chemical modification and furthermore it involves easy sample
manipulation. Overall this has important consequences for the
data discussion and the final decision of the embryologist.4. Conclusions
The objective of this study was to determine the composition of
the commercial embryo culture medium. We have shown the
versatility of HPLC-UV-Vis, HPLC-MS and 1H NMR spec-
troscopy as well as the appropriate procedure optimisation in
order to analyse as many analytes as possible, present in 20–30
mL of real sample after embryo development. Although the
presence of interferences such as proteins and glycosaminogly-
cans and the high level of osmolality of the IVF media, just
a conditioning procedure based on a derivatisation step, was
required for the amino acids analysis. Additionally, we exploit
the LC as a routine, easy and accessible technique for non-expert
technicians at chemical and biological laboratories, and the
NMR as a powerful technique which contributes simultaneously
to both determine new molecules and provide the whole
metabolomic profile of the culture medium.
A rapid compositiondetermination couldbe achieved relatively
fast as the analysis takes no longer than 12 minutes for glucose
mass determination, 8 minutes for pyruvic and lactic acids
quantification and a complete separation of ten amino acids in 70
minutes. Furthermore, we show here the possibility of obtaining
an NMR fingerprint by screening the global sample composition
in order to get a glance at it in just 11minutes which is not possible
with any chromatography. This combinatory approach provides
a versatile methodology which would help the embryologist in the
evaluation or assessment process of the embryo viability.Acknowledgements
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